Show simple item record

dc.contributor.authorMeyer, Stefan
dc.contributor.authorBarber, Lisa M
dc.contributor.authorWhite, Daniel J
dc.contributor.authorWill, Andrew M
dc.contributor.authorBirch, Jillian M
dc.contributor.authorKohler, Janice A
dc.contributor.authorErsfeld, Klaus
dc.contributor.authorBlom, Eric
dc.contributor.authorJoenje, Hans
dc.contributor.authorEden, Tim O B
dc.contributor.authorTaylor, Malcolm G
dc.date.accessioned2009-07-06T11:23:50Z
dc.date.available2009-07-06T11:23:50Z
dc.date.issued2006-05
dc.identifier.citationSpectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia. 2006, 133 (3):284-92 Br. J. Haematol.en
dc.identifier.issn0007-1048
dc.identifier.pmid16643430
dc.identifier.doi10.1111/j.1365-2141.2006.05985.x
dc.identifier.urihttp://hdl.handle.net/10541/72555
dc.description.abstractChildhood acute myeloid leukaemia (AML) is uncommon. Children with Fanconi anaemia (FA), however, have a very high risk of developing AML. FA is a rare inherited disease caused by mutations in at least 12 genes, of which Fanconi anaemia group G gene (FANCG) is one of the commonest. To address to what extent FANCG variants contribute to sporadic childhood AML, we determined the spectrum of FANCG sequence variants in 107 children diagnosed with sporadic AML, using polymerase chain reaction (PCR), fluorescent single-strand conformational polymorphism (SSCP) and sequencing methodologies. The significance of variants was determined by frequency analysis and assessment of evolutionary conservation. Seven children (6.5%) carried variants in FANCG. Two of these carried two variants, including the known IVS2 + 1G>A mutation with the novel missense mutation S588F, and R513Q with the intronic deletion IVS12-38 (-28)_del11, implying that these patients might have been undiagnosed FA patients. R513Q, which affects a semi-conserved amino acid, was carried in two additional children with AML. Although not significant, the frequency of R513Q was higher in children with AML than unselected cord bloods. While FANCG mutation carrier status does not predispose to sporadic AML, the identification of unrecognised FA patients implies that FA presenting with primary AML in childhood is more common than suspected.
dc.language.isoenen
dc.subjectCancer DNAen
dc.subjectFanconi Anaemiaen
dc.subjectLeukaemiaen
dc.subject.meshAcute Disease
dc.subject.meshAdolescent
dc.subject.meshAmino Acid Sequence
dc.subject.meshAnimals
dc.subject.meshChild
dc.subject.meshChild, Preschool
dc.subject.meshDNA, Neoplasm
dc.subject.meshFanconi Anemia
dc.subject.meshFanconi Anemia Complementation Group G Protein
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshLeukemia, Myeloid
dc.subject.meshMale
dc.subject.meshMolecular Sequence Data
dc.subject.meshMutation
dc.subject.meshPolymerase Chain Reaction
dc.subject.meshPolymorphism, Single-Stranded Conformational
dc.subject.meshSequence Alignment
dc.titleSpectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia.en
dc.typeArticleen
dc.contributor.departmentDepartment of Paediatric Haematology and Oncology, Central Manchester and Manchester Children's University Hospital and Christie Hospital NHS Trusts, Manchester, UK. stefan.meyer-2@manchester.ac.uken
dc.identifier.journalBritish Journal of Haematologyen
html.description.abstractChildhood acute myeloid leukaemia (AML) is uncommon. Children with Fanconi anaemia (FA), however, have a very high risk of developing AML. FA is a rare inherited disease caused by mutations in at least 12 genes, of which Fanconi anaemia group G gene (FANCG) is one of the commonest. To address to what extent FANCG variants contribute to sporadic childhood AML, we determined the spectrum of FANCG sequence variants in 107 children diagnosed with sporadic AML, using polymerase chain reaction (PCR), fluorescent single-strand conformational polymorphism (SSCP) and sequencing methodologies. The significance of variants was determined by frequency analysis and assessment of evolutionary conservation. Seven children (6.5%) carried variants in FANCG. Two of these carried two variants, including the known IVS2 + 1G>A mutation with the novel missense mutation S588F, and R513Q with the intronic deletion IVS12-38 (-28)_del11, implying that these patients might have been undiagnosed FA patients. R513Q, which affects a semi-conserved amino acid, was carried in two additional children with AML. Although not significant, the frequency of R513Q was higher in children with AML than unselected cord bloods. While FANCG mutation carrier status does not predispose to sporadic AML, the identification of unrecognised FA patients implies that FA presenting with primary AML in childhood is more common than suspected.


This item appears in the following Collection(s)

Show simple item record